Szkudlinski M W, Thotakura N R, Weintraub B D
Molecular and Cellular Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9062-6. doi: 10.1073/pnas.92.20.9062.
The recombinant human thyroid stimulating hormone (rhTSH) containing oligosaccharides terminated with NeuAc(alpha 2-3)Gal(beta 1-4)GlcNAc beta 1 showed higher in vivo activity and lower metabolic clearance rate (MCR) than pituitary human TSH (phTSH), which contains oligosaccharides terminating predominantly in SO(4)4GalNAc(beta 1-4)GlcNAc beta 1. To elucidate the relative contribution of the sulfated and sialylated carbohydrate chains of each subunit in the MCR and bioactivity of the hormone, the alpha and beta subunits of phTSH, rhTSH, and enzymatically desialylated rhTSH (asialo-rhTSH; asrhTSH) were isolated, their oligosaccharides were analyzed, and the respective subunits were dimerized in various combinations. The hybrids containing alpha subunit from phTSH or asrhTSH showed higher in vitro activity than those with alpha subunit from rhTSH, indicating that sialylation of alpha but not beta subunit attenuates the intrinsic activity of TSH. In contrast, hybrids with beta subunit from rhTSH displayed lower MCR compared to those with beta subunit from phTSH. The phTSH alpha-rhTSH beta hybrid had the highest in vivo bioactivity followed by rhTSH alpha-rhTSH beta, rhTSH alpha-phTSH beta, phTSH alpha-phTSH beta, and asrhTSH dimers. These differences indicated that hybrids with beta subunit from rhTSH displayed the highest in vivo activity and relatively low MCR, probably due to higher sialylation, more multiantennary structure, and/or the unique location of the beta-subunit oligosaccharide chain in the molecule. Thus, the N-linked oligosaccharides of the beta subunit of glycoprotein hormones have a more pronounced role than those from the alpha subunit in the metabolic clearance and thereby in the in vivo bioactivity. In contrast, the terminal residues of alpha-subunit oligosaccharides have a major impact on TSH intrinsic potency.
与垂体人促甲状腺激素(phTSH)相比,含有以NeuAc(α2-3)Gal(β1-4)GlcNAcβ1结尾的寡糖的重组人促甲状腺激素(rhTSH)在体内活性更高,代谢清除率(MCR)更低。phTSH的寡糖主要以SO(4)4GalNAc(β1-4)GlcNAcβ1结尾。为了阐明每个亚基的硫酸化和唾液酸化糖链对激素MCR和生物活性的相对贡献,分离了phTSH、rhTSH和酶促去唾液酸化的rhTSH(脱唾液酸-rhTSH;asrhTSH)的α和β亚基,分析了它们的寡糖,并将各个亚基以各种组合方式二聚化。含有phTSH或asrhTSH的α亚基的杂合体在体外活性高于含有rhTSH的α亚基的杂合体,这表明α亚基而非β亚基的唾液酸化会减弱TSH的内在活性。相反,与含有phTSH的β亚基的杂合体相比,含有rhTSH的β亚基的杂合体MCR更低。phTSHα-rhTSHβ杂合体具有最高的体内生物活性,其次是rhTSHα-rhTSHβ、rhTSHα-phTSHβ、phTSHα-phTSHβ和asrhTSH二聚体。这些差异表明,含有rhTSH的β亚基的杂合体在体内活性最高且MCR相对较低,这可能是由于更高的唾液酸化、更多的多天线结构和/或β亚基糖链在分子中的独特位置。因此,糖蛋白激素β亚基的N-连接寡糖在代谢清除以及由此产生的体内生物活性方面比α亚基的寡糖发挥更显著的作用。相反,α亚基寡糖的末端残基对TSH的内在效力有重大影响。